PLoS ONE (Jan 2021)

Validation of conventional PCR-like alternative to SARS-CoV-2 detection with target nucleocapsid protein gene in naso-oropharyngeal samples.

  • Rogério Fernandes Carvalho,
  • Monike da Silva Oliveira,
  • Juliane Ribeiro,
  • Isac Gabriel Cunha Dos Santos,
  • Katyane de Sousa Almeida,
  • Ana Carolina Muller Conti,
  • Bruna Alexandrino,
  • Fabrício Souza Campos,
  • Célia Maria de Almeida Soares,
  • José Carlos Ribeiro Júnior

DOI
https://doi.org/10.1371/journal.pone.0257350
Journal volume & issue
Vol. 16, no. 9
p. e0257350

Abstract

Read online

SARS-CoV-2 has spread worldwide and has become a global health problem. As a result, the demand for inputs for diagnostic tests rose dramatically, as did the cost. Countries with inadequate infrastructure experience difficulties in expanding their qPCR testing capacity. Therefore, the development of sensitive and specific alternative methods is essential. This study aimed to develop, standardize, optimize, and validate conventional RT-PCR targeting the N gene of SARS-CoV-2 in naso-oropharyngeal swab samples compared to qPCR. Using bioinformatics tools, specific primers were determined, with a product expected to be 519 bp. The reaction conditions were optimized using a commercial positive control, and the detection limit was determined to be 100 fragments. To validate conventional RT-PCR, we determined a representative sampling of 346 samples from patients with suspected infection whose diagnosis was made in parallel with qPCR. A sensitivity of 92.1% and specificity of 100% were verified, with an accuracy of 95.66% and correlation coefficient of 0.913. Under current Brazilian conditions, this method generates approximately 60% savings compared to qPCR costs. Conventional RT-PCR, validated herein, showed sufficient results for the detection of SARS-CoV-2 and can be used as an alternative for epidemiological studies and interspecies correlations.